Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $27.8500 (-6.95%) ($27.8500 - $27.8500) on Thu. Dec. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.54% (three month average) | RSI | 39 | Latest Price | $27.8500(-6.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(70%) IWO(64%) IBUY(62%) IWC(62%) IWM(60%) | Factors Impacting EDIT price | EDIT will decline at least -2.27% in a week (0% probabilities). VIXM(-33%) UUP(-15%) VXX(-12%) TBT(-9%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.27% (StdDev 4.54%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $14.82(-46.79%) | Resistance Level | $31.05 | 5 Day Moving Average | $28.96(-3.83%) | 10 Day Moving Average | $29.4(-5.27%) | 20 Day Moving Average | $31.05(-10.31%) | To recent high | -56% | To recent low | 0.7% | Market Cap | $1.73b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |